标签：#Biotech & Health

Vijay Pande — who left a16z's roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a "discovery" science to an "engineering" one, why clinical trials are still brutally expensive, and why he thinks open, shared datasets (not walled-off ones) are what will actually let AI transform medicine.

Hoomanely has developed a smart bowl to measure and record dogs' feeding data, then tells owners if behaviors change.

The company won't say if medical devices are affected or if any customer data was exfiltrated.

Michael Polansky — better known publicly as Lady Gaga's partner and a former top deputy to Sean Parker — has quietly spent years building an AI-driven startup that keeps living human skin tissue alive for weeks outside the body to discover new skincare compounds, and is only now going public about it.

An effort to transform the world of sports through steroid use doesn't exactly seem to be bearing financial fruit.

It's the data, stupid.

The scanning and bloodwork health startup founded by Spotify's founder will officially launch in New York in about a month.

The plaintiffs say they invested nearly $1.2 million in the company, and are accusing Gomez of failing to build and market the startup.

The health tech data giant, which handles vast amounts of patients' medical data, said hackers struck one of its protected health data stores.

"The thing that the space needs is a company making $100 million a year of revenue," Science Corp. CEO Max Hodak said.

The four-year-old firm's latest fund is 60% larger than its second vehicle announced 18 months ago.

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Neko Health has developed proprietary body-scanning technology, which it couples with bloodwork, to assess a person's health.

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs's words, a huge part of what Yosemite does. "I didn't expect Yosemite to be moving this fast," he said.

Anthropic's Claude Science is a workbench that gives scientists one environment to do computational research, saving them from the need to bounce between databases, pipelines, and tools.

Save up to $190 on your pass to TechCrunch Founder Summit 2026. Early Bird pricing ends today, at 11:59 p.m. PT, after which rates increase. Register now.

The new round values the physical AI startup that aims to automate heavy engineering and drug design at $41 billion.

Applications for Startup Battlefield 200 officially close on June 8, 11:59 p.m. PT. Don't wait any longer. Secure your shot at competing on the Disrupt Stage at TechCrunch Disrupt 2026 this October at San Francisco's Moscone West.

The Enhanced Games — a singular sporting competition where a majority of the athletes were on performance enhancing drugs — may herald a new business model that the tech industry is ready to embrace.